Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Retrospective Analysis of the Impact of Bendamustine Dose Reduction and Chemotherapy on the Outcomes of Follicular Lymphoma

Yusuke Koba, Kazuhiro Bandai, Naoko Hiranuma, Kensuke Fujiwara, Takahito Kawata, Akira Tamekane, Mitsumasa Watanabe

Blood (2023) 142 (Supplement 1): 6167.

https://doi.org/10.1182/blood-2023-179228

Published: 2023

Journal Articles

Detection of Cells with Low Side Scatter and Dimmer CD45 Expression after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Good Survival

Yoshimitsu Shimomura, MD, Hayato Maruoka, M.T, Yotaro Ochi, MD, Yusuke Koba, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD, PhD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2015) 126 (23): 3207.

https://doi.org/10.1182/blood.V126.23.3207.3207

Published: 2015

Journal Articles

Bone Marrow Involvement Detected By Ig Heavy Chain Rearrangement Has an Negative Impact of Progression Free Survival Independently of IPI and FDG-PET in Diffuse Large B-Cell Lymphoma

Yuichiro Ono, MD, Daisuke Kato, MD, Tomohiro Yabushita, MD, Yoshimitsu Shimomura, MD, Yusuke Koba, MD, Yotaro Ochi, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD, PhD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Yukihiro Imai, MD, PhD, Hayato Maruoka, M.T, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2015) 126 (23): 1480.

https://doi.org/10.1182/blood.V126.23.1480.1480

Published: 2015

Journal Articles

The Significance of Serum Albumin Level and Platelet Count in Patients with Diffuse Large B-Cell Lymphoma in the Context of an Enhanced International Prognostic Index (NCCN-IPI)

Yotaro Ochi, MD, Yusuke Koba, MD, Yoshimitsu Shimomura, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Satoshi Yoshioka, MD, PhD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Yukihiro Imai, MD, PhD, Takayuki Ishikawa, MD, PhD

Blood (2015) 126 (23): 1463.

https://doi.org/10.1182/blood.V126.23.1463.1463

Published: 2015

Journal Articles

Risk Stratification of DLBCL Patients According to NCCN-IPI in Our Hospital

Yasuhiro Kazuma, MD, Kazunari Aoki, MD, Yotaro Ochi, MD, Yusuke Koba, MD, Yoshimitsu Shimomura, MD, Yosuke Nagahata, MD, Nobuhiko Yamauchi, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 3030.

https://doi.org/10.1182/blood.V124.21.3030.3030

Published: 2014

Journal Articles

Emergence of New lesions upon Treatment failure is an Independent, Negative Prognostic Factor for Patients with Primary Refractory DLBCL

Nobuhiko Yamauchi, MD, Yusuke Koba, MD, Yotaro Ochi, MD, Yasuhiro Kazuma, MD, Yosuke Nagahata, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Yukihiro Imai, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 2962.

https://doi.org/10.1182/blood.V124.21.2962.2962

Published: 2014

Journal Articles

Combined Use of Interim Positron Emission Tomography Scans and Serum Soluble Interleukin-2 Receptor Values Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma

Yotaro Ochi, MD, Nobuhiko Yamauchi, MD, Yusuke Koba, MD, Yasuhiro Kazuma, MD, Yosuke Nagahata, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Megumu Hino, MD, PhD, Yukihiro Imai, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 1647.

https://doi.org/10.1182/blood.V124.21.1647.1647

Published: 2014

Journal Articles

The Significance and Optimal Number of Cycles of HD-AraC Consolidation Chemotherapy for Non-CBF AML

Yosuke Nagahata, MD, Yoshimitsu Shimomura, MD, Yotaro Ochi, MD, Yusuke Koba, MD, Yasuhiro Kazuma, MD, Nobuhiko Yamauchi, MD, Yuichiro Ono, MD, Nobuhiro Hiramoto, MD, Sumie Tabata, MD, PhD, Noboru Yonetani, MD, Akiko Matsushita, MD, Hisako Hashimoto, MD, PhD, Takayuki Ishikawa

Blood (2014) 124 (21): 2298.

https://doi.org/10.1182/blood.V124.21.2298.2298

Published: 2014

Journal Articles

Decision-Making At The End Of Consolidation Of Acute Myeloid Leukemia: Negative Effect Of Minimal Residual Disease Detectable With Multiparametric Flowcytometry Combined With Gene Mutations Of FLT3 On Early Relapse

Yuichiro Ono, M.D., June Takeda, M.D., Hayato Maruoka, Yasuhiro Kazuma, M.D., Nobuhiro Hiramoto, MD, Nobuhiko Yamauchi, M.D., Yosuke Nagahata, M.D., Yuki Funayama, M.D., Yotaro Ochi, MD, Yusuke Koba, MD, Sumie Tabata, M.D., Ph.D., Noboru Yonetani, M.D., Akiko Matsushita, M.D., Koji Nasu, Takayuki Takahashi, M.D., Ph.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 3921.

https://doi.org/10.1182/blood.V122.21.3921.3921

Published: 2013

Journal Articles

Azacitidine Improves Survival in Myelodysplastic Syndromes; Single Institute Retrospective Study

June Takeda, M.D., Nobuhiko Yamauchi, M.D., Kazunari Aoki, MD, Yuichiro Ono, M.D., Yuki Funayama, M.D., Yasuhiro Kazuma, M.D., Yosuke Nagahata, M.D., Yotaro Ochi, MD, Yusuke Koba, MD, Sumie Tabata, M.D., Ph.D., Nobuhiro Hiramoto, M.D., Akiko Matsushita, M.D., Noboru Yonetani, M.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 5215.

https://doi.org/10.1182/blood.V122.21.5215.5215

Published: 2013

Journal Articles

Allo-HSCT From Unrelated Donors Improves The Outcome Of Elderly AML Patients In CR1

Yosuke Nagahata, M.D., Yuichiro Ono, M.D., Yotaro Ochi, MD, Yusuke Koba, MD, Yasuhiro Kazuma, M.D., June Takeda, M.D., Yuki Funayama, M.D., Nobuhiko Yamauchi, M.D., Nobuhiro Hiramoto, M.D., Sumie Tabata, M.D., Ph.D., Noboru Yonetani, M.D., Akiko Matsushita, M.D., Hisako Hashimoto, M.D., Ph.D., Takayuki Ishikawa, M.D., Ph.D.

Blood (2013) 122 (21): 2166.

https://doi.org/10.1182/blood.V122.21.2166.2166

Published: 2013

NARROW

Retrospective Analysis of the Impact of Bendamustine Dose Reduction and Chemotherapy on the Outcomes of Follicular Lymphoma

Detection of Cells with Low Side Scatter and Dimmer CD45 Expression after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Good Survival

Bone Marrow Involvement Detected By Ig Heavy Chain Rearrangement Has an Negative Impact of Progression Free Survival Independently of IPI and FDG-PET in Diffuse Large B-Cell Lymphoma

The Significance of Serum Albumin Level and Platelet Count in Patients with Diffuse Large B-Cell Lymphoma in the Context of an Enhanced International Prognostic Index (NCCN-IPI)

Risk Stratification of DLBCL Patients According to NCCN-IPI in Our Hospital

Emergence of New lesions upon Treatment failure is an Independent, Negative Prognostic Factor for Patients with Primary Refractory DLBCL

Combined Use of Interim Positron Emission Tomography Scans and Serum Soluble Interleukin-2 Receptor Values Predicts Survival in Patients with Diffuse Large B-Cell Lymphoma

The Significance and Optimal Number of Cycles of HD-AraC Consolidation Chemotherapy for Non-CBF AML

Decision-Making At The End Of Consolidation Of Acute Myeloid Leukemia: Negative Effect Of Minimal Residual Disease Detectable With Multiparametric Flowcytometry Combined With Gene Mutations Of FLT3 On Early Relapse

Azacitidine Improves Survival in Myelodysplastic Syndromes; Single Institute Retrospective Study

Allo-HSCT From Unrelated Donors Improves The Outcome Of Elderly AML Patients In CR1

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only